EFPIA - NEWSLETTER

EFPIA Newsletter 20 July 2022

Blogs

20 July 2022 The Czech plan to beat cancer

The Czech Republic’s long-awaited National Cancer Plan matches ambition on screening and tackling inequality with hard...

19 July 2022 Primary health care is key to solving the diabetes challenge

Rethinking health systems demands investment in primary health care systems to manage rising rates of chronic diseases...

18 July 2022 European Association of Urology 2022: Collaborating to translate urological cancer innovation...

We are not standing still in our efforts to provide better care for patients, and there are much-needed novel innovations...

Innovative Clinical Trials

"Patients with unmet needs are longing for innovative treatments to be approved. Especially rare disease patients, where only 5-6% have approved treatments, need a new strategy to speed up research and provide new opportunities to access innovative drugs. Complex clinical trials can be the change that patients want to see".
Claas Röhl, chairman of NF Patients United

Better fit research into patients' lives

"New trials enable participants to continue with their day-to-day lives with minimal disruption", says Jenny Camaradou, clinical trials participant and EUPATI patient expert.

Unlocking new benefits for patients & medical research

"Ambitions are high, and it’s not always easy, but #WeWontRest until we get to the innovative design that improves and accelerates drug development" says Ann Van Dessel, VP Regulatory and Clinical

Recently published

EU pharma in numbers: a portrait of an industry at a crossroads 29 June 2022 (News & Events)

The Pharmaceutical Industry in Figures 2022 reveals a keystone of the European economy at a pivotal moment in its history...

The EFPIA Disclosure: Where are we for the 7th publication? 23 June 2022 (News & Events)

In the context of increasing societal expectations on transparency, the disclosure requirements seek to address any...

What we are reading

This unicorn is betting on AI to boost drug discovery. It’s now one big step closer 20 July 2022 (Euronews)

The case for diabetes screening and early detection 20 July 2022 (Euractiv)

WIPO Assemblies Open: Director General Calls on Delegates to Transform IP into a Powerful Catalyst... 14 July 2022 (WIPO)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶